Recently, a novel imaging modality, prostate-specific membrane antigen emission tomography (PSMA PET), has demonstrated potential as an adjunctive or alternative imaging technique for primary prostate cancer diagnosis [2]. Here, FOLH1 is linked to prostate carcinoma.